Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood (2005)
- Authors:
- USP affiliated authors: QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- Subjects: LEUCEMIA; PEDIATRIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Pediatric Blood and Cancer
- ISSN: 1545-5009
- Volume/Número/Paginação/Ano: v. 45, n. 4, p. 426, res. P. A. 009, 2005
- Conference titles: Annual Conference of the International Society of Paediatric Oncology
-
ABNT
OLIVEIRA, E. Morato de; OLIVEIRA, Fábio Morato de; SCRIDELI, Carlos Alberto; et al. Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood. Pediatric Blood and Cancer[S.l: s.n.], 2005. -
APA
Oliveira, E. M. de, Oliveira, F. M. de, Scrideli, C. A., Biojone, E., Queiroz, R. P., Valera, E. T. V., & Tone, L. G. (2005). Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood. Pediatric Blood and Cancer. Hoboken. -
NLM
Oliveira EM de, Oliveira FM de, Scrideli CA, Biojone E, Queiroz RP, Valera ETV, Tone LG. Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood. Pediatric Blood and Cancer. 2005 ; 45( 4): 426. -
Vancouver
Oliveira EM de, Oliveira FM de, Scrideli CA, Biojone E, Queiroz RP, Valera ETV, Tone LG. Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood. Pediatric Blood and Cancer. 2005 ; 45( 4): 426. - Study of the protein expression of the matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in tumors from ewing family and medulloblastoma of children and adolescents
- Expression of matrix metalloproteinase-9 (MMP-9) and their tissue inhibitor (TIMP-1) in brain tumors
- Estudo dos polimorfismos no gene CDKNIA em eduloblastomas, astrocitomas e ependimomas em crianças e adolescentes
- Expressão da metaloproteinase 9 (e seu inibidor (TIMP-1) em tumores de sistema nervoso central pediatricos
- Polimorfismos em genes do biometabolismo (NQO1 e NAT2) e de reparo do DNA (XRCC1) e risco reduzido de leucemia linfoblástica aguda na infância
- The cytochrome P450 2D6 G1934A gene polymorphism and risk of childhood lymphoblastic leukemia
- Quantitative analysis of N-MYC by real time PCR (RQ-PCR) in human neuroblastoma. A simplified strategy
- Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia
- Polymorphisms in the thymidylate synthase promoter and the DNA repair genes XRCC1 and XPD in a Brazilian population
- PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphological analysis and risk group classification
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
